Lubiprostone
These highlights do not include all the information needed to use LUBIPROSTONE CAPSULES safely and effectively. See full prescribing information for LUBIPROSTONE CAPSULES. LUBIPROSTONE capsules, for oral useInitial U.S. Approval: 2006
6c11a204-6831-4269-a3c4-1702ed83f74b
HUMAN PRESCRIPTION DRUG LABEL
Mar 27, 2023
Zydus Pharmaceuticals USA Inc.
DUNS: 156861945
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Lubiprostone
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
Lubiprostone
Product Details
FDA regulatory identification and product classification information